Literature DB >> 468446

Chronopharmacokinetics of dipyridamole.

A Markiewicz, K Semenowicz, J Korczynska, A Czachowska.   

Abstract

The experiment carried out in 6 volunteers shows a better availability of a 75 mg single oral dose of dipyridamole administered at 600 than at 2200. The availability of dipyridamole administered at 600. The dependence of kel and t0.5(elim) on the time of drug administration is less distinct.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 468446

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Biopharm        ISSN： 0340-0026


  5 in total

1.  Chronopharmacokinetic study with prolonged infusion of midazolam.

Authors:  U Klotz; I W Reimann
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of antiplatelet agents used in the secondary prevention of stroke.

Authors:  Thomas Lenz; Amy Wilson
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Circadian effect on carbamazepine kinetics in rat.

Authors:  B Bruguerolle; M Valli; L Bouyard; G Jadot; P Bouyard
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

4.  Pharmacokinetics of oral dipyridamole (Persantine) and its effect on platelet adenosine uptake in man.

Authors:  A Dresse; C Chevolet; D Delapierre; H Masset; H Weisenberger; G Bozler; G Heinzel
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 5.  Translating around the clock: Multi-level regulation of post-transcriptional processes by the circadian clock.

Authors:  Amber A Parnell; Aliza K De Nobrega; Lisa C Lyons
Journal:  Cell Signal       Date:  2020-12-25       Impact factor: 4.315
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.